Your browser doesn't support javascript.
loading
Combination product of dermal matrix, preconditioned human mesenchymal stem cells and timolol promotes wound healing in the porcine wound model.
Yang, Hsin-Ya; Fierro, Fernando; Yoon, Daniel J; Gallegos, Anthony; Osborn, Stephanie L; Nguyen, Alan V; Peavy, Thomas R; Ferrier, William; Talken, Linda; Ma, Betty W; Galang, Kristopher G; Medina Lopez, Andrea; Fregoso, Daniel R; Stewart, Heather; Kurzrock, Eric A; Soulika, Athena M; Nolta, Jan A; Isseroff, R Rivkah.
  • Yang HY; Department of Dermatology, School of Medicine, University of California Davis Health System, Sacramento, California, USA.
  • Fierro F; Department of Cell Biology and Human Anatomy, University of California Davis Health System, Sacramento, California, USA.
  • Yoon DJ; Stem Cell Program, Department of Internal Medicine, University of California Davis Health System, Sacramento, California, USA.
  • Gallegos A; Department of Dermatology, School of Medicine, University of California Davis Health System, Sacramento, California, USA.
  • Osborn SL; Department of Dermatology, School of Medicine, University of California Davis Health System, Sacramento, California, USA.
  • Nguyen AV; Stem Cell Program, Department of Internal Medicine, University of California Davis Health System, Sacramento, California, USA.
  • Peavy TR; Department of Urologic Surgery, School of Medicine, University of California Davis Health System, Sacramento, California, USA.
  • Ferrier W; Department of Dermatology, School of Medicine, University of California Davis Health System, Sacramento, California, USA.
  • Talken L; Institute for Pediatric Regenerative Medicine, Shriners Hospital for Children Northern California, Sacramento, California, USA.
  • Ma BW; Department of Biological Sciences, California State University, Sacramento, Sacramento, California, USA.
  • Galang KG; Large Animal Survival Surgery Facility, Stem Cell Program, University of California Davis Health System, Sacramento, California, USA.
  • Medina Lopez A; Large Animal Survival Surgery Facility, Stem Cell Program, University of California Davis Health System, Sacramento, California, USA.
  • Fregoso DR; Campus Veterinary Services Clinic, Office of Research, University of California, Davis, Davis, California, USA.
  • Stewart H; Campus Veterinary Services Clinic, Office of Research, University of California, Davis, Davis, California, USA.
  • Kurzrock EA; Residency Program in Laboratory Animal/Primate Medicine, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
  • Soulika AM; Department of Dermatology, School of Medicine, University of California Davis Health System, Sacramento, California, USA.
  • Nolta JA; Department of Dermatology, School of Medicine, University of California Davis Health System, Sacramento, California, USA.
  • Isseroff RR; Stem Cell Program, Department of Internal Medicine, University of California Davis Health System, Sacramento, California, USA.
J Biomed Mater Res B Appl Biomater ; 110(7): 1615-1623, 2022 07.
Article en En | MEDLINE | ID: mdl-35099112
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article